Prior Authorization Delays in Healthcare Revenue Cycle

Prior authorization delays can hold up revenue long before a claim is ever filed. Procedures sit on the schedule waiting for approval, staff time goes to phone calls and resubmissions, and accounts receivable can age while a payer decides. The financial effect is easy to overlook because it rarely shows up as its own line item, which is why it deserves attention from the controllership team as well as the billing office.

The administrative load is well documented. The AMA’s 2025 physician survey found that prior authorization consumes an average of 13 hours of physician and staff time each week, and that 40% of physicians employ staff dedicated exclusively to prior authorization tasks. That is time not spent on patient care, scheduling or collections.

How Prior Authorization Delays Affect Your Bottom Line

When clinical teams wait on payer approvals, revenue sits in limbo. The practice has already incurred costs for the initial visit, diagnostic work and care coordination, but the procedure can’t be scheduled, billed or moved through the revenue cycle until authorization comes through.

The financial impact can compound quickly. Accounts receivable ages while approvals are pending. Staff time gets absorbed by phone calls and resubmissions. Some patients abandon care altogether, which leaves unbilled services behind and weakens outcomes data.

Payer requirements add another layer because they aren’t standardized. A service one payer approves with little friction can require extensive documentation and multiple review steps from another. Billing teams end up learning different portals, forms, documentation requirements and appeal processes for every payer contract the organization holds.

The Operational Cost Behind the Delay

Prior authorization delays create hidden costs beyond the obvious revenue impact. Front-office staff end up working as a prior authorization department, which takes time away from scheduling, patient communication and insurance verification. Clinical staff get pulled into documentation requests and peer-to-peer reviews. Productivity drops across the practice.

Many healthcare organizations don’t track the fully loaded cost of authorization delays. They know procedures are delayed, but few can put a dollar figure on a day of delay, name the payers that cause the longest holdups or identify the procedure codes that trigger the most denials. Without that data, decisions about staffing, technology investments and payer contract negotiations rest on anecdote instead of metrics.

What the CMS Prior Authorization Rule Means for Cash Flow

Federal rules are starting to put prior authorization on a clock. Under CMS’s prior authorization final rule, Medicare Advantage, Medicaid and CHIP plans must send decisions within 72 hours for expedited requests and seven calendar days for standard requests. They must also give a specific reason when a request is denied. Those operational requirements began January 1, 2026, and drug authorizations are excluded.

For the payers the rule covers, tracking turnaround time against those timeframes gives your team a clear basis for escalation and contract conversations. Commercial payers fall outside the rule, so it helps to confirm which payers in your mix are covered before setting expectations.

Take Control of Your Authorization Process

Smart healthcare organizations treat prior authorization as a controllership issue as well as a billing issue. They track authorization volume, turnaround time and denial patterns by payer and procedure type, then use that data to find bottlenecks, improve workflows and negotiate stronger contract terms.

Technology can help with submissions and status tracking, but it works best with clear processes behind it. Authorization work sits at the front of the revenue cycle, alongside scheduling and insurance verification, so ownership usually fits best with the team already handling those steps. That team also needs a defined path for escalating denials and a set trigger for starting peer-to-peer reviews.

A few practices tend to separate organizations that control the problem from those that absorb it:

Your controllership team can also monitor days in accounts receivable attributable to authorization delays separately from other AR metrics. That separate view shows whether delays are improving or getting worse over time, and it supports the business case for additional staffing or technology when the numbers justify it.

Build a Better System

Prior authorization delays won’t disappear anytime soon, but their financial impact can be reduced. Start with visibility into the current state: how many authorizations the practice processes, the average turnaround time and which payers and procedures create the longest delays.

Once baseline data is in place, improvement targets and progress measures become possible. Adding one dedicated authorization specialist may reduce overall delays more cost-effectively than expensive technology. A small share of procedure codes may also turn out to drive most of the delays, which lets the team focus its improvement efforts where they matter.

Treating this as a controllership and financial management issue gives the organization a way to quantify the problem and track the metrics. Accounting, billing and clinical operations staff can work closely together to drive continuous improvement. James Moore’s revenue cycle enhancement services help practices and health systems build this infrastructure and analyze revenue cycle data. Contact us when you’re ready to see what authorization delays are costing your organization.

All content provided in this article is for informational purposes only. Matters discussed in this article are subject to change. For up-to-date information on this subject please contact a James Moore professional. James Moore will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.